{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:46:16Z","timestamp":1782344776908,"version":"3.54.5"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T00:00:00Z","timestamp":1711670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.biopha.2024.116529","type":"journal-article","created":{"date-parts":[[2024,4,2]],"date-time":"2024-04-02T00:29:47Z","timestamp":1712017787000},"page":"116529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Protective effect of esculentoside A against myocardial infarction via targeting C-X-C motif chemokine receptor 2"],"prefix":"10.1016","volume":"174","author":[{"given":"Meng","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehua","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoya","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6785-5471","authenticated-orcid":false,"given":"Lina","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116529_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121821","article-title":"Cardiac-specific overexpression of catalase attenuates lipopolysaccharide-induced cardiac anomalies through reconciliation of autophagy and ferroptosis","volume":"328","author":"Peng","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2024.116529_bib2","article-title":"Elevated levels of alcohol dehydrogenase aggravate ethanol-evoked cardiac remodeling and contractile anomalies through FKBP5-yap-mediated regulation of ferroptosis and ER stress","volume":"19","author":"Lu","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.biopha.2024.116529_bib3","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1016\/j.amjmed.2022.08.017","article-title":"Mechanical complications of myocardial infarction","volume":"135","author":"Murphy","year":"2022","journal-title":"Am. J. Med."},{"key":"10.1016\/j.biopha.2024.116529_bib4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.tcm.2017.07.011","article-title":"Predicting death after acute myocardial infarction","volume":"28","author":"Castro-Dominguez","year":"2018","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.biopha.2024.116529_bib5","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/CIR.0000000000000351","volume":"133","author":"Mehta","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2024.116529_bib6","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1161\/CIR.0000000000000985","volume":"144","author":"Damluji","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2024.116529_bib7","doi-asserted-by":"crossref","first-page":"399","DOI":"10.26599\/1671-5411.2023.06.001","article-title":"Report on cardiovascular health and diseases in China 2021: an updated summary","volume":"20","author":"T.W.C.O.T.R.O.C.H.A.D. In China","year":"2023","journal-title":"J. Geriatr. Cardiol."},{"key":"10.1016\/j.biopha.2024.116529_bib8","article-title":"Tetra-ARMS PCR analysis of angiotensinogen AGT T174M (rs4762) genetic polymorphism in diabetic patients: a comprehensive study","volume":"25","author":"Akash","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.biopha.2024.116529_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3390\/metabo13020251","article-title":"Biochemical association of MTHFR C677T polymorphism with myocardial infarction in the presence of diabetes mellitus as a risk factor","volume":"9","author":"Mallhi","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.biopha.2024.116529_bib10","first-page":"473","article-title":"Biochemical association between the prevalence of genetic polymorphism and myocardial infarction","volume":"47","author":"SHAHID","year":"2023","journal-title":"BIOCELL Tech. Sci. Press."},{"key":"10.1016\/j.biopha.2024.116529_bib11","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.3390\/metabo12121291","article-title":"Genetic polymorphism in angiotensinogen and its association with cardiometabolic diseases","volume":"12","author":"Shahid","year":"2022","journal-title":"Metabolites"},{"key":"10.1016\/j.biopha.2024.116529_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2023.101661","article-title":"A comprehensive review: epidemiological strategies, catheterization and biomarkers used as a bioweapon in diagnosis and management of cardio vascular diseases","volume":"48","author":"Abbas","year":"2023","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.biopha.2024.116529_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102468","article-title":"Fibroblast growth factor 7 alleviates myocardial infarction by improving oxidative stress via PI3K\u03b1\/AKT-mediated regulation of Nrf2 and HXK2","volume":"56","author":"Mei","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.biopha.2024.116529_bib14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/s41392-022-00925-z","article-title":"Signaling pathways and targeted therapy for myocardial infarction","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.biopha.2024.116529_bib15","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/febs.15865","article-title":"Structural insights into the activation of chemokine receptor CXCR2","volume":"289","author":"Liu","year":"2022","journal-title":"FEBS J."},{"key":"10.1016\/j.biopha.2024.116529_bib16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/s41569-019-0260-8","article-title":"NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets","volume":"17","author":"Zhang","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.biopha.2024.116529_bib17","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction: from inflammation to Fibrosis","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2024.116529_bib18","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.pharmthera.2018.01.001","article-title":"Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities","volume":"186","author":"Ong","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2024.116529_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2022.101398","article-title":"Novel therapeutic strategies to reduce reperfusion injury after acute myocardial infarction","volume":"47","author":"Sch\u00e4fer","year":"2022","journal-title":"Curr. Probl. Cardiol."},{"key":"10.1016\/j.biopha.2024.116529_bib20","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJMoa1706222","article-title":"DETO2X\u2013Swedeheart Investigators, Oxygen therapy in suspected acute myocardial infarction","volume":"377","author":"Hofmann","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.biopha.2024.116529_bib21","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0140-6736(13)61452-X","article-title":"Future treatment strategies in ST-segment elevation myocardial infarction","volume":"382","author":"Windecker","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2024.116529_bib22","first-page":"774","article-title":"The pathophysiology of acute myocardial infarction and strategies of protection beyond reperfusion: a continual challenge","volume":"38","author":"Heusch","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2024.116529_bib23","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jchf.2017.09.015","article-title":"Post-myocardial infarction heart failure","volume":"6","author":"Bahit","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.biopha.2024.116529_bib24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bja.2021.10.039","article-title":"Reduction of NETosis by targeting CXCR1\/2 reduces thrombosis, lung injury, and mortality in experimental human and murine sepsis","volume":"128","author":"Alsabani","year":"2022","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.biopha.2024.116529_bib25","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.7150\/thno.15625","article-title":"Role of the CXCL8-CXCR1\/2 axis in cancer and inflammatory diseases","volume":"7","author":"Ha","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2024.116529_bib26","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.nbd.2017.06.001","article-title":"CXCL1\/CXCR2 signaling in pathological pain: role in peripheral and central sensitization","volume":"105","author":"Silva","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.biopha.2024.116529_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115175","article-title":"Expanding role of CXCR2 and therapeutic potential of CXCR2 antagonists in inflammatory diseases and cancers","volume":"250","author":"Xie","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116529_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108257","article-title":"Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases","volume":"237","author":"Dhayni","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2024.116529_bib29","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1093\/eurheartj\/ehy085","article-title":"CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration","volume":"39","author":"Wang","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2024.116529_bib30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s13287-021-02332-7","article-title":"Upregulated anti-angiogenic miR-424-5p in type 1 diabetes (model of subclinical cardiovascular disease) correlates with endothelial progenitor cells, CXCR1\/2 and other parameters of vascular health","volume":"12","author":"Tamara","year":"2021","journal-title":"Stem Cell Res. Ther."},{"key":"10.1016\/j.biopha.2024.116529_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2019.165551","article-title":"Chronic inhibition of chemokine receptor CXCR2 attenuates cardiac remodeling and dysfunction in spontaneously hypertensive rats","author":"Zhang","year":"2019","journal-title":"Biochim. Biophys. Acta Mol. Basis. Di. S. 1865"},{"key":"10.1016\/j.biopha.2024.116529_bib32","doi-asserted-by":"crossref","first-page":"11272","DOI":"10.1111\/jcmm.15694","article-title":"Selective blocking of CXCR2 prevents and reverses atrial fibrillation in spontaneously hypertensive rats","volume":"24","author":"Zhang","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.biopha.2024.116529_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153753","article-title":"Herbs and their bioactive ingredients in cardio-protection: underlying molecular mechanisms and evidences from clinical studies","volume":"92","author":"Kumar","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2024.116529_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114929","article-title":"Buyang Huanwu Decoction promotes angiogenesis in myocardial infarction through suppression of PTEN and activation of the PI3K\/Akt signalling pathway","volume":"287","author":"Han","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2024.116529_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114841","article-title":"Qishen granule (QSG) exerts cardioprotective effects by inhibiting NLRP3 inflammasome and pyroptosis in myocardial infarction rats","volume":"285","author":"Chen","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.biopha.2024.116529_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.biotechadv.2019.01.010","article-title":"Curcumin, the golden spice in treating cardiovascular diseases","volume":"38","author":"Li","year":"2020","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.biopha.2024.116529_bib37","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.yjmcc.2019.09.012","article-title":"Effects of the combination of tanshinone IIA and puerarin on cardiac function and inflammatory response in myocardial ischemia mice","volume":"137","author":"Gao","year":"2019","journal-title":"J. Mol. Cell Cardiol."},{"key":"10.1016\/j.biopha.2024.116529_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120855","article-title":"An injectable peptide hydrogel with excellent self-healing ability to continuously release salvianolic acid B for myocardial infarction","volume":"274","author":"Chen","year":"2021","journal-title":"Biomaterials"},{"issue":"PTR","key":"10.1016\/j.biopha.2024.116529_bib39","article-title":"Nephrotoxicity assessment of Esculentoside A using human-induced pluripotent stem cell-derived organoids","author":"Gu","year":"2023","journal-title":"Phytother. Res."},{"key":"10.1016\/j.biopha.2024.116529_bib40","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/s41419-018-0581-2","article-title":"The ginsenoside PPD exerts anti-endometriosis effects by suppressing estrogen receptor-mediated inhibition of endometrial stromal cell autophagy and NK cell cytotoxicity","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.biopha.2024.116529_bib41","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.freeradbiomed.2016.11.009","article-title":"Nrf2-mediated liver protection by esculentoside A against acetaminophen toxicity through the AMPK\/Akt\/GSK3\u03b2 pathway","volume":"101","author":"Wang","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.biopha.2024.116529_bib42","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ejphar.2017.07.029","article-title":"Esculentoside A inhibits LPS-induced BV2 microglia activation through activating PPAR-\u03b3","volume":"813","author":"Li-hua","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2024.116529_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106376","article-title":"Esculentoside A protects against osteoarthritis by ameliorating inflammation and repressing osteoclastogenesis","volume":"82","author":"Shao","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2024.116529_bib44","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.intimp.2017.08.014","article-title":"Esculentoside A exerts anti-inflammatory activity in microglial cells","volume":"51","author":"Yang","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2024.116529_bib45","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1161\/CIRCRESAHA.110.223925","article-title":"A novel and efficient model of coronary artery ligation and myocardial infarction in the mouse","volume":"107","author":"Gao","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.biopha.2024.116529_bib46","article-title":"Dioscin alleviates myocardial infarction injury via regulating BMP4\/NOX1-mediated oxidative stress and inflammation","volume":"103","author":"Zhang","year":"2022","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.biopha.2024.116529_bib47","doi-asserted-by":"crossref","first-page":"7995","DOI":"10.7150\/thno.50990","article-title":"Ablation of lncRNA Miat attenuates pathological hypertrophy and heart failure","volume":"11","author":"Yang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2024.116529_bib48","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.3390\/ijms20184331","article-title":"Molecular docking: shifting paradigms in drug discovery","volume":"20","author":"Pinzi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116529_bib49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drudis.2021.09.007","article-title":"Machine-learning methods for ligand-protein molecular docking","volume":"27","author":"Crampon","year":"2022","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2024.116529_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2021.118644","article-title":"Application of molecular docking in elaborating molecular mechanisms and interactions of supramolecular cyclodextrin","volume":"276","author":"Li","year":"2022","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biopha.2024.116529_bib51","first-page":"51","article-title":"Celastrol suppresses colorectal cancer via covalent targeting peroxiredoxin 1, Signal Transduct","volume":"8","author":"Xu","year":"2023","journal-title":"Target. Ther."},{"key":"10.1016\/j.biopha.2024.116529_bib52","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.ijbiomac.2021.06.017","article-title":"A potential antiviral activity of Esculentoside A against binding interactions of SARS-COV-2 spike protein and angiotensin converting enzyme 2 (ACE2)","volume":"31","author":"Zeng","year":"2021","journal-title":"Int J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2024.116529_bib53","doi-asserted-by":"crossref","first-page":"15395","DOI":"10.1016\/j.phymed.2022.153956","article-title":"Esculentoside A alleviates cognitive deficits and amyloid pathology through peroxisome proliferator-activated receptor \u03b3-dependent mechanism in an Alzheimer\u2019s disease model","volume":"98","author":"He","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.biopha.2024.116529_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2021.113711","article-title":"CXCL5\/CXCR2 modulates inflammation-mediated neural repair after optic nerve injury","volume":"341","author":"Liu","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.biopha.2024.116529_bib55","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.4049\/jimmunol.2100229","article-title":"Macrophagic extracellular vesicle CXCL2 recruits and activates the neutrophil CXCR2\/PKC\/NOX4 Axis in sepsis","volume":"207","author":"Wang","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.biopha.2024.116529_bib56","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/eji.201847710","article-title":"F. D\u00edaz-Gonz\u00e1lez, L-selectin expression is regulated by CXCL8-induced reactive oxygen species produced during human neutrophil rolling","volume":"49","author":"Dom\u00ednguez-Luis","year":"2019","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.biopha.2024.116529_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108257","article-title":"Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases","volume":"237","author":"Dhayni","year":"2022","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.biopha.2024.116529_bib58","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1093\/eurheartj\/ehy085","article-title":"CXCL1-CXCR2 axis mediates angiotensin II-induced cardiac hypertrophy and remodelling through regulation of monocyte infiltration","volume":"39","author":"Wang","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.biopha.2024.116529_bib59","first-page":"1272","article-title":"Selective blocking of CXCR2 prevents and reverses atrial fibrillation in spontaneously hypertensive rats","volume":"24","author":"Zhang","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.biopha.2024.116529_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104480","article-title":"A small-molecule inhibitor of Keap1-Nrf2 interaction attenuates sepsis by selectively augmenting the antibacterial defence of macrophages at infection sites","volume":"90","author":"Wang","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.biopha.2024.116529_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2024.121795","article-title":"A chemo\/chemodynamic nanoparticle based on hyaluronic acid induces ferroptosis and apoptosis for triple-negative breast cancer therapy","volume":"329","author":"Wang","year":"2024","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.biopha.2024.116529_bib62","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2023.12.038","article-title":"Apigenin-7-glucoside-loaded nanoparticle alleviates intestinal ischemia-reperfusion by ATF3\/SLC7A11-mediated ferroptosis","volume":"366","author":"Zhao","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2024.116529_bib63","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/jssc.201901140","article-title":"Development of an ultra-high-performance liquid chromatography coupled with triple quadrupole mass spectrometry method for comparative pharmacokinetics of six triterpenoids in rat plasma and application to different forms of Phytolacca acinosa","volume":"43","author":"Tao","year":"2020","journal-title":"J. Sep. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222400413X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222400413X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T22:48:25Z","timestamp":1782341305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222400413X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":63,"alternative-id":["S075333222400413X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116529","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effect of esculentoside A against myocardial infarction via targeting C-X-C motif chemokine receptor 2","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116529","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116529"}}